Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 1004 results for "us fda"

Jubilant Life receives US FDA approval for hypertension drug telmisartan
Business Standard

US FDA grants approval to Jubilant's hypertension drug felodipine

The approved product, felodipine extended-release tablet (2.5 mg, 5 mg, and 10 mg), is the generic version of Plendil tablets of AstraZeneca BS B2B Bureau | Noida (UP) August 26, 2016 Last Updated at 13:56 IST Jubilant Life Sciences Ltd has received final ... Business Standard, 1 day ago
[x]  

1,593 images for us fda

Business Standard, 3 days ago
Business Standard India, 1 week ago
Business Standard, 2 weeks ago
Livemint.com, 2 weeks ago
Money Control, 2 weeks ago
BioSpace, 2 days ago
Scrip Intelligence, 2 days ago
Business Standard India, 2 weeks ago
Freshnews.com, 3 days ago
Reuters, 1 day ago
India Infoline

Natco Pharma up 7%, receives EIR from USFDA for Chennai plant

The company has received a successful establishment inspection report (EIR) from the US food and drug administration (FDA) for its chemical division, Chennai, India.
 Money Control2 days ago Granules India receives EIR from USFDA; stock up 4.5%  India Infoline2 months ago

Good rain, base effect to lift earnings in second half: TVF Cap

The healthcare sector is facing many US Food and Drug Administration (FDA) hurdles. This is only a temporary turmoil, he says. The big Pharma names from India have huge opportunities in the US as the demand for generic drugs from India steadily rises.
 Money Control4 days ago
Money Control

Lupin looks to launch 25 products in US this fiscal

"We expect to launch a good number of products between India and Gavis (US). We are hoping to launch 25 plus products, FDA permitting. So, a good number of launches that we expect for the year," Lupin CEO Vinita Gupta said in a conference call.
 Money Control5 days ago Lupin to launch 25 products in US this fiscal  Hindu Business Line1 week ago Curry Products Recalled Over Lead  Industrial Equipment News1 week ago Expanding mkts, launching new products for growth: Wockhardt  Moneycontrol.com1 week ago
[x]  
Livemint.com

Sun Pharma: hopes pinned on FDA clearance for Halol plant

Till its Halol facility gets a green signal, Sun Pharma's approval pipeline will continue to look dull The going continues to be tough for Sun Pharmaceutical Industries Ltd. Earlier last week, its US unit Taro Pharmaceutical Industries Ltd reported ...
 Livemint.com1 week ago Alembic Pharma: Hurdles cleared  Business Line1 month ago Sun Pharma: No acquisition opportunities?  Business Standard2 months ago Sun Pharma projects 8% revenue growth for FY17  Business Line2 months ago

U.S. FDA issues GRAS No Objection Letter for NIAGEN®

IRVINE, Calif., Aug. 15, 2016 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an innovator of proprietary health, wellness and nutritional ingredients that creates science-based solutions to dietary supplement, food and beverage, skin care, ...
 Benzinga.com1 week ago US FDA issues GRAS No Objection Letter for NIAGEN  Pharma Focus Asia1 week ago BRIEF-Chromadex- FDA issues GRAS no objection letter to Niagen  Reuters UK1 week ago
[x]  
Pharma Letter

FDA finds drug class at centre of French trial tragedy do not pose similar safety risks

The US Food and Drug Administration (FDA) has issued a statement following the results of their investigation into the recent Rennes clinical trial tragedy which indicates that other FAAH inhibitors do not pose similar safety risks to BIA 10-2474. ...
 Pharmafile1 week ago FDA: 'Unique' Toxicity With Failed French Drug  General Medicine eJournal2 weeks ago Investigational drugs in the USA related to BIA 10-2474 do not pose similar safety risks, says FDA  Pharma Letter2 weeks ago

FDAnews Announces — New Management Report — Effective 483 Responses: FOCUS on CAPA Violations

Regulatory law expert Glenn Demby has culled the best, and some of the worst responses the FDA has received. In the new management report Effective 483 Responses, he'll walk readers through which responses were good and which were not, so they can ...
 Benzinga.com1 week ago FDAnews Announces -- New Management Report -- Effective 483 Responses: FOCUS on CAPA Violations  Minyanville1 week ago
[x]  

BRIEF-UBI Pharma passes U.S FDA review of clinical trial in human for anticancer drug

Deals of the day-Mergers and acquisitions Aug 15 The following bids, mergers, acquisitions and disposals were reported by 1000 GMT on Monday: U.S. mulls long-term, bomb-grade uranium exports to Belgium * Bomb-grade uranium exports would be ...
 Reuters UK1 week ago

The FDA, Juno Therapeutics, and the ethical imperative of transparency

Spencer Phillips Hey , research fellow 1 2 , Aaron S Kesselheim , associate professor of medicine 1 2 1 Program on Regulation, Therapeutics, and Law (PORTAL), division of pharmacoepidemiology and pharmacoeconomics, Brigham and Women's Hospital, ...
 British Medical Journal1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less